Lowering Cardiovascular Disease Risk for People with Severe Mental Illnesses in Primary Care: A Focus Group Study

PloS One
Alexandra BurtonKate Walters

Abstract

People with severe mental illnesses die early from cardiovascular disease. Evidence is lacking regarding effective primary care based interventions to tackle this problem. To identify current procedures for, barriers to, and facilitators of the delivery of primary care based interventions for lowering cardiovascular risk for people with severe mental illnesses. 75 GPs, practice nurses, service users, community mental health staff and carers in UK GP practice or community mental health settings were interviewed in 14 focus groups which were audio-recorded, transcribed and analysed using Framework Analysis. Five barriers to delivering primary care based interventions for lowering cardiovascular risk in people with severe mental illnesses were identified by the groups: negative perceptions of people with severe mental illnesses amongst some health professionals, difficulties accessing GP and community-based services, difficulties in managing a healthy lifestyle, not attending appointments, and a lack of awareness of increased cardiovascular risk in people with severe mental illnesses by some health professionals. Identified facilitators included involving supportive others, improving patient engagement with services, continuity of...Continue Reading

References

Jan 22, 2000·BMJ : British Medical Journal·C PopeN Mays
Apr 4, 2006·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Judith McDevittJoellen Wilbur
Jun 24, 2008·Psychology, Health & Medicine·Marita P McCabe, Loranie Leas
Mar 10, 2009·Journal of Psychosocial Nursing and Mental Health Services·Trine TetlieRoger Almvik
Mar 26, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lawrence MaayanChristoph U Correll
May 4, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Daniel Tai-yin TsoiAngela Claire Webster
Jun 18, 2010·The Cochrane Database of Systematic Reviews·Daniel T TsoiAngela C Webster
Jan 3, 2012·Psychiatric Services : a Journal of the American Psychiatric Association·Alexandra L PitmanMichael B King
Nov 6, 2013·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Bridget BassiliosPhilippa Pattison
Jun 3, 2014·Psychiatric Rehabilitation Journal·Elizabeth A KlingamanRichard W Goldberg

❮ Previous
Next ❯

Citations

Apr 29, 2018·Community Mental Health Journal·Vesna ZupančičTina Kogovšek
Apr 2, 2019·Irish Journal of Psychological Medicine·Benjamin O'Keeffe, Vincent Russell
Mar 14, 2019·The British Journal of Psychiatry : the Journal of Mental Science·Niklaus StulzUrs Hepp
Jul 25, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·W GaebelJ Stricker
Sep 24, 2020·Journal of Psychiatric and Mental Health Nursing·Jennifer D WoodChristine Barber
Dec 10, 2020·International Journal of Mental Health Systems·Mª Carmen Castillejos AnguianoBerta Moreno Küstner

❮ Previous
Next ❯

Software Mentioned

QSR
Excel
NVivo9

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2021 Meta ULC. All rights reserved